Cancer

November 5, 2020

Screening younger women for hereditary cancers may be cost effective

Population-wide screening for genetic variants linked to hereditary breast and ovarian cancer may be cost effective in women between the ages of 20 and 35, according to a study published in JAMA Network Open.

By Tom Wilemon
October 29, 2020

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

By Tom Wilemon
October 29, 2020

New markers of colorectal cancer risk

Vanderbilt epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo.

By Sarah E. Glass
October 26, 2020

Philadelphia Eagles pick VUMC resident to sing national anthem before game

The lifelong Eagles fan closed “The Star-Spangled Banner” with a big smile and the exhortation “Go, Birds!”

By Wayne Wood
bacteria microbiome
October 20, 2020

Preserving gut mucus architecture

A new method that keeps microbes and gut cells together will be useful for studies of complex host-microbe interactions and for analysis of clinical specimens.

By Leigh MacMillan
October 9, 2020

Erlanger Health System and Vanderbilt-Ingram Cancer Center partner in cancer care

Erlanger Health System and Vanderbilt University Medical Center, on behalf of Vanderbilt-Ingram Cancer Center (VICC), have entered into a professional service agreement designing a long-term collaboration in comprehensive cancer care, including VICC hematology-oncology services at Erlanger Oncology and Hematology and infusion locations.

By VUMC News and Communications
September 29, 2020

VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center

Vanderbilt-Ingram Cancer Center (VICC) received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the National Cancer Institute (NCI) and places it once again in a top group of NCI Comprehensive Cancer Centers.
By Tom Wilemon
September 24, 2020

VICC leading first global study of MDS/MPN overlap syndrome

Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
By Tom Wilemon
September 17, 2020

Chic Awearness Sept. 24 virtual event to focus on ovarian cancer research

Chic Awearness, in collaboration with the Vanderbilt-Ingram Cancer Center, will host a virtual event on Sept. 24 focusing on ovarian cancer research and its impact during COVID-19.
By Tom Wilemon
September 17, 2020

New predictors of prostate cancer risk

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.
By Sarah E. Glass
August 27, 2020

Vanderbilt-Ingram opens cancer center in Wilson County

Vanderbilt-Ingram Cancer Center at Wilson County is slated to open Aug. 31 with a full array of highly specialized services, including diagnostic assessments, medical oncology and radiation oncology.
By Tom Wilemon
August 26, 2020

Chang named Vanderbilt-Ingram Cancer Center chief surgical officer

Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties.
By Tom Wilemon
August 25, 2020

Blocking tumor ‘signals’ and ‘fuel’

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.
By Leigh MacMillan
1 … 27 28 29 30 31 … 72